As a member of the Quantitative Sciences & Innovation (QSI) unit in Biomarker Development, you will join Novartis’ clinical trial teams to speed new medicines into the clinic across one of the industry’s largest and most innovative portfolios. By integrating large-scale genomic and biomarker profiles from First In Human through Phase III clinical trials, you will investigate disease heterogeneity, drug efficacy, and patient safety at molecular resolution to advance trials in new indications and patient populations. You are passionate and curious scientist, eager to bring creative solutions to biology’s most daunting challenges on our journey to reimagine medicine. Working alongside dedicated physicians and biomarker scientists, our Investigators provide the analytical insights that drive Translational success.
Your responsibilities will include:
What you’ll bring to the role:
WHY CONSIDER NOVARTIS?
750 million. That’s how many lives our products touch. And while we’re proud of that fact, in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?
We believe the answers are found when curious, courageous and collaborative people like you are empowered to ask new questions, make bolder decisions and take smarter risks.
We are Novartis. Join us and help us reimagine medicine.
Novartis Pharma AG
Research & Development